Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01204788 · ClinicalTrials.gov registry record · Phase 2
Prophylactic White Cell Transfusions Versus Therapeutic White Cell Transfusions in Patients With Leukemia
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT01204788: Clinical Trial Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT01204788 is a Phase 2 study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01204788, a Phase 2 study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
Patients with leukemia often have low white blood cell counts after chemotherapy, which puts them at greater risk for infection. The standard of care for preventing infections is to give these patients antibiotic, antifungal, and antiviral drugs during the time that white blood cell counts are low. However, many patients still develop infections during chemotherapy. Radiated white blood cell transfusions are a standard treatment once a patient develops a severe infection. The goal of this clinical research study is to learn if giving unirradiated white blood cell transfusions early in chemotherapy might delay or prevent infections in patients with leukemia. Researchers also want to learn more about the type and severity of any infections that do occur.
Interventions
- PROCEDURE Prophylactic White Cell Transfusion
- PROCEDURE Therapeutic White Cell Transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01204788
The ClinicalTrials.gov registry entry for NCT01204788 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prophylactic White Cell Transfusion is the first listed.
NCT01204788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01204788 about?
NCT01204788 is a clinical study titled "Prophylactic White Cell Transfusions Versus Therapeutic White Cell Transfusions in Patients With Leukemia". Patients with leukemia often have low white blood cell counts after chemotherapy, which puts them at greater risk for infection. The standard of care for preventing infections is to give these patients antibiotic, antifungal, and antiviral drugs during the time that white blood cell counts are low. ...
What is the current status of trial NCT01204788?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2010-09. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01204788?
The interventions under investigation include: Prophylactic White Cell Transfusion (PROCEDURE), Therapeutic White Cell Transfusion (PROCEDURE).
Who is sponsoring clinical trial NCT01204788?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.